Pharmacotherapy Treatment in Substance-Dependent Correctional Populations: A Review

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Substance Use & Misuse

• Publication date

  2005-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/10826080500294866PMID 16282089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 動向レビュー 英国の図書館における健康情報サービス--National electronic Library for Health(NeLH)

  2004cited by this paper
• The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic.

  2003cited by this paper
• Public policy statement on access to appropriate detoxification services for persons incarcerated in prisons and jails.

  2003cited by this paper
• A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.

  2003influential reference
• Methadone maintenance expands inside federal prisons.

  2002influential reference
• Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone.

  2002influential reference
• Needle Exchange Programs

  2002cited by this paper
• The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.

  2002cited by this paper
• Drug-Substitution Treatment in Germany: A Critical Overview of Its History, Legislation and Current Practice

  2002cited by this paper
• A novel opioid maintenance program for prisoners: preliminary findings.

  2002cited by this paper
• Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials.

  2001cited by this paper
• Institutional Methadone Maintenance Treatment: Impact on Release Outcome and Institutional Behaviour

  2001influential reference
• Needle exchange programs in prisons in Spain.

  2000influential reference
• Drugs and Prisoners: Treatment Needs on Entering Prison*

  2000cited by this paper
• Syringe exchange and risk of infection with hepatitis B and C viruses.

  1999cited by this paper
• Drug use and injection risk-taking among prison methadone maintenance patients.

  1998influential reference
• Methadone maintenance treatment reduces heroin injection in New South Wales prisons.

  1998influential reference
• Substance use in remand prisoners: a consecutive case study.

  1998influential reference
• Concealed breast cancer causes delayed treatment

  1998cited by this paper
• Provision of syringes: the cutting edge of harm reduction in prison?

  1998influential reference
• Substance misusers remanded to prison--a treatment opportunity?

  1998cited by this paper
• The provision of methadone within prison settings

  1998influential reference
• Methadone in provincial prisons in British Columbia.

  1997cited by this paper
• High-dose naltrexone and liver function safety.

  1997cited by this paper
• Naltrexone pharmacotherapy for opioid dependent federal probationers.

  1997influential reference
• Methadone in provincial prisons in British Columbia.

  1997cited by this paper
• An International Review of Methadone Provision in Prisons

  1996influential reference
• Hiv Risk Behaviour of Idus Before, During and After Imprisonment in New South Wales

  1996cited by this paper
• AIDS behind bars: preventing HIV spread among incarcerated drug injectors.

  1995cited by this paper
• Methadone maintenance treatment.

  1995cited by this paper
• Lack of Hepatotoxicity with Naltrexone Treatment

  1994cited by this paper
• The Effectiveness of In-Jail Methadone Maintenance

  1993influential reference
• Effects of Long-Term Treatment with Naltrexone on Hepatic Enzyme Activity

  1991cited by this paper
• Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children.

  1989cited by this paper
• Naltrexone: Lack of Effect on Hepatic Enzymes

  1988cited by this paper
• The criminal justice system and opiate addiction: a historical perspective.

  1988cited by this paper
• Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage.

  1986cited by this paper
• Methadone maintenance treatment.

  1985cited by this paper
• Naltrexone treatment in a jail work-release program.

  1984influential reference
• The importance of dose in isocarboxazid therapy.

  1984cited by this paper
• Naltrexone and behavior therapy for heroin addiction.

  1979influential reference
• Naltrexone and cyclazocine. A controlled treatment study.

  1977influential reference
• Methadone treatment of randomly selected criminal addicts.

  1969influential reference

• The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial.

  2025cites this paper
• Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: the Geographic variation in Addiction Treatment Experiences (GATE) longitudinal cohort study protocol

  2023cites this paper
• A meta-analysis on the effects of incarceration-based opioid substitution treatment

  2022cites this paper
• Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada

  2022cites this paper
• Applying the socio-ecological model to understand community reintegration experiences among individuals on opioid agonist treatment (OAT) released from federal incarceration in Ontario, Canada

  2022cites this paper
• The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update.

  2020cites this paper
• Effectiveness of prison-based opioid substitution treatment: a systematic review

  2018cites this paper
• Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial

  2017cites this paper
• American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use

  2015cites this paper
• Risks Inside and Beyond Institutional Walls: Organisational Responses to Substance Use in Canadian Federal Prisons

  2014cites this paper
• Characteristics of Women Participants in the Methadone Maintenance Treatment Program (MMTP)

  2014cites this paper
• Treatments for Offenders in Prison and the Community

  2012cites this paper
• The Study of the Demographic and Clinical and Laboratory Findings in Naltrexone Poisoning Patients Admitted to Razi Hospital, Rasht, During 2007-08

  2012cites this paper
• Substance Use Prevalence in Criminal Justice Settings

  2011cites this paper
• Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system.

  2011cites this paper
• Criminal Justice System and Addiction Treatment

  2010cites this paper
• A randomized trial of oral naltrexone for treating opioid-dependent offenders.

  2010influential citation
• Naltrexone Implants Compared to Methadone: Outcomes Six Months after Prison Release

  2010cites this paper
• Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions.

  2009influential citation
• Application of a Standardized Assessment Methodology Within the Context of an Evidence-Based Treatment for Substance Abuse and Its Associated Problems

  2009cites this paper
• Treatment research in prison: Problems and solutions in a randomized trial

  2009cites this paper
• Justice System: Improving Public Health and Safety Treating Drug Abuse and Addiction in the Criminal

  2009cites this paper
• Drug Abuse Treatment Beyond Prison Walls

  2009cites this paper
• Treating drug abuse and addiction in the criminal justice system: improving public health and safety.

  2009cites this paper
• International Public Health and Corrections: Models of Care and Harm Minimization

  2007cites this paper
• Women and the Criminal Justice System

  2006cites this paper
• Costs and benefits of combining probation and substance abuse treatment.

  2006cites this paper